Expanding HER2 horizons: Implications for NSCLC and beyond
55:13
Precision targeting of MET in NSCLC: A multidisciplinary approach
31:53
Perspectives on EGFR-mutant and wildtype NSCLC: Tailoring treatment advances in late-stage disease
55:22
Targeting BCMA in multiple myeloma: Insights from COMy and EHA 2024
33:26
Pharmacological management of agitation in Alzheimer’s dementia
1:15:11
Demência em Estágio Inicial? 6 Sinais que Você Precisa Conhecer
40:30
Continuous glucose monitoring in type 2 diabetes: Overcoming barriers to optimize outcomes
24:02
ASCO 2024: Advances in Targeted Therapy for Lung Cancer
27:28